CELLPhenomeX Inc


$ 1.00 $ 0.00 (0.31 %)    

Friday, 29-Sep-2023 15:56:54 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 0.9981
$ 1.00
$ 0.00 x 0
$ 0.00 x 0
$ 1.00 - $ 1.00
$ 0.38 - $ 3.65
203,908
na
na
$ 2.21
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 phenomex-announces-the-release-of-spotlight-human-lambda-reagent-for-the-beacon-platform-to-accelerate-cell-line-development-workflows

Preliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16th annual PEACe Conference EMERYVILLE, Calif....

 phenomex-unveils-meteor-chips-for-quantitative-bulk-analysis-on-the-isospark-platform-to-revolutionize-high-throughput-multiplexed-hands-free-proteomic

Fully quantitative bulk and comprehensive single cell proteomics are now both available on the IsoSpark platform 

 td-cowen-downgrades-phenomex-to-market-perform-announces-1-price-target

TD Cowen analyst Steven Mah downgrades PhenomeX (NASDAQ:CELL) from Outperform to Market Perform and announces $1 price target.

 berenberg-downgrades-phenomex-to-hold-lowers-price-target-to-1

Berenberg analyst Gaurav Goparaju downgrades PhenomeX (NASDAQ:CELL) from Buy to Hold and lowers the price target from $8 to $1.

 morgan-stanley-upgrades-phenomex-to-equal-weight-announces-1-price-target

Morgan Stanley analyst Tejas Savant upgrades PhenomeX (NASDAQ:CELL) from Underweight to Equal-Weight and announces $1 price ...

 dow-tumbles-over-100-points-lsi-industries-shares-spike-higher

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 100 points on Thursday. The Dow trade...

 bruker-enters-functional-single-cell-biology-research-solutions-with-phenomex-acquisition

Bruker Corporation (NASDAQ: BRKR) has agreed to acquire PhenomeX Inc (NASDAQ: CELL) for $1.00 per share in an 

 why-nice-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 millio...

 crude-oil-moves-higher-walmart-raises-guidance

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Thursday. The Dow trade...

 phenomex-shares-resume-trade
PhenomeX Shares Resume Trade
08/17/2023 13:50:31

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION